Epidermal growth factor enhances the intestinal adaptation of small bowel allografts in the postoperative period.
Kato
Y
Y
Second Department of Surgery, Kansai Medical University, Osaka, Japan. katoy@takii.kmu.ac.jp
Hamada
Y
Y
Nakai
K
K
Okumura
T
T
Hioki
K
K
D000818:Animals; D001835:Body Weight; D004815:Epidermal Growth Factor / Q000627:therapeutic use*; D005947:Glucose / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000166:cytology / Q000502:physiology / Q000637:transplantation*; D007583:Jejunum / Q000502:physiology* / Q000637:transplantation*; D008297:Male; D011184:Postoperative Period; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000627:therapeutic use; D014184:Transplantation, Homologous / Q000276:immunology / Q000379:methods / Q000502:physiology*
D007166:Immunosuppressive Agents; D004815:Epidermal Growth Factor; D005947:Glucose; D016559:Tacrolimus